Real-time enrollment status for this newly diagnosed multiple myeloma (ndmm) clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:06 PM UTC
| NCT Number | NCT07735637 |
| Recruiting Status | Recruiting |
| Condition | Newly Diagnosed Multiple Myeloma (NDMM) |
| Phase | PHASE3 |
| Target Enrollment | 750 participants |
| Active Locations | 46 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | October 21, 2026 (22 hours ago) |
As of October 21, 2026: Clinical trial NCT07735637 is currently recruiting participants. This phase3 study for newly diagnosed multiple myeloma (ndmm) is actively seeking new participants at 46 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07735637 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 46 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07735637 was last updated 22 hours ago (October 21, 2026). HelloStudys verifies this status automatically.